Radoslaw Targonski
Overview
Explore the profile of Radoslaw Targonski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
165
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rudzinski P, Henzel J, Witkowski A, Dabrowski M, Huczek Z, Wojakowski W, et al.
Am J Cardiol
. 2024 Mar;
217:25-28.
PMID: 38432337
What is the efficacy and safety of transcatheter tricuspid valve-in-valve implantation for patients with inoperable tricuspid surgical prosthesis dysfunction? Thirty-day mortality after greatly effective transcatheter treatment is 2 times less...
2.
Fezzi S, Jagielak D, Targonski R, Schmidt T, Frerker C, Witkowski A, et al.
EuroIntervention
. 2024 Feb;
20(4):e264-e267.
PMID: 38389472
No abstract available.
3.
Walczewski M, Gasecka A, Witkowski A, Dabrowski M, Huczek Z, Wilimski R, et al.
Postepy Kardiol Interwencyjnej
. 2023 Oct;
19(3):251-256.
PMID: 37854972
Introduction: Data regarding patients with a previous medical record of immunosuppression treatment who have undergone transcatheter aortic valve implantation (TAVI) are limited and extremely inconclusive. Available studies are mostly short...
4.
Blazejowska E, Zimodro J, Figatowski T, Brzeski A, Dziubich T, Parzuchowski J, et al.
Cardiol J
. 2023 Oct;
30(5):846-848.
PMID: 37822077
No abstract available.
5.
Huczek Z, Protasiewicz M, Dabrowski M, Parma R, Hudziak D, Olszowka P, et al.
Kardiol Pol
. 2023 Jun;
81(6):646-668.
PMID: 37319015
Over 15 years of clinical experience and multiple large-scale observational studies followed by guidelines show good safety and efficacy of valve-in-valve transcatheter aortic valve implantation TAVI (ViV-TAVI), which reduces the...
6.
Bohdan M, Kolaczkowska M, Radtke-Lysek A, Targonski R, Siondalski P, Rogowski J, et al.
Kardiol Pol
. 2023 May;
81(7-8):796-797.
PMID: 37222250
No abstract available.
7.
Huczek Z, Mazurek M, Kochman J, Kralisz P, Jagielak D, Sacha J, et al.
Kardiol Pol
. 2023 Apr;
81(6):606-612.
PMID: 37096948
Background: Valve-in-valve transcatheter transfemoral mitral valve implantation (ViV-TMVI) is an emerging treatment alternative to reoperation in high-surgical risk patients with failed mitral bioprostheses. Aim: We aimed to describe the characteristics...
8.
Pluta K, Porebska K, Urbanowicz T, Gasecka A, Olasinska-Wisniewska A, Targonski R, et al.
Biology (Basel)
. 2022 Nov;
11(11).
PMID: 36358348
The authors would like to make the following correction to the published paper [...].
9.
Targonski R, Gasecka A, Luis M, Jagielak D, Jaguszewski M, Piazza N
Catheter Cardiovasc Interv
. 2022 Sep;
100(5):915-922.
PMID: 36054254
Despite easy access to imaging diagnostic procedures and an abundance of spatial data, most cardiac interventions are still performed under two-dimensional fluoroscopy. Incorporating anatomical data from scans into procedures plans...
10.
Gasecka A, Walczewski M, Witkowski A, Dabrowski M, Huczek Z, Wilimski R, et al.
Front Cardiovasc Med
. 2022 Jul;
9:894497.
PMID: 35800165
Objectives: Patients with bicuspid aortic valve (BAV) stenosis were excluded from the pivotal trials of transcatheter aortic valve implantation (TAVI). We compared the in-hospital and long-term outcomes between patients undergoing...